Hepion Pharmaceuticals, Inc. (HEPA) › Capital ExpendituresHepion Pharmaceuticals, Inc. (HEPA) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2014: $15.8K2015: $83.3K2016: $6.6K2017: $14.7K2019: $51.5K2020: $88.0K2021: $130.4K2022: $16.3K2023: $14.3K$14.3K2014Capital Expenditures (USD)2023Fiscal YearCapital ExpendituresChange YoY2023$14.3K-12.4%2022$16.3K-87.5%2021$130.4K+48.2%2020$88.0K+70.9%2019$51.5K—2017$14.7K+122.8%2016$6.6K-92.1%2015$83.3K+425.5%2014$15.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share